Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocannabinoid overactivity and intestinal inflammation.

V Di Marzo1, A A Izzo

  • 1Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, via Campi Flegrei 34, 80078 Pozzuoli, Napoli, Italy. vdimarzo@icmib.na.cnr.it

Gut
|September 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Gut Microbes Produce EPA- and DHA-Derived Oxylipins, but not N-Acyl-Ethanolamines, From Fish Oil.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025
Same author

Dietary targeting of TRPM8 rewires macrophage immunometabolism reducing colitis severity.

Cell death & disease·2025
Same author

Modulation of CB1 and CB2 receptors and endocannabinoid activity in inflammatory bowel diseases.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2024
Same author

Probiotic interventions promote metabolic health in high fat-fed hamsters in association with gut microbiota and endocannabinoidome alterations.

Beneficial microbes·2023
Same author

Kahweol, a natural diterpene from coffee, induces peripheral antinociception by endocannabinoid system activation.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2021
Same author

The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients.

Pharmacological research·2019

The gastrointestinal endocannabinoid system, involving cannabinoid receptors (CB1, CB2) and endocannabinoids, regulates digestive functions. Inflammation can lead to endocannabinoid overactivity, suggesting therapeutic potential.

Area of Science:

  • Gastroenterology
  • Neurogastroenterology
  • Pharmacology

Background:

  • The gastrointestinal system possesses cannabinoid receptors (CB1, CB2), endocannabinoids, and related biosynthesis/inactivation mechanisms.
  • Endocannabinoid activation of CB1 receptors influences esophageal sphincter relaxation, gastric acid secretion, and intestinal motility.
  • Cannabinoid receptor stimulation affects various gastrointestinal functions beyond these primary roles.

Purpose of the Study:

  • To discuss the pathological significance of endocannabinoid system overactivity in gastrointestinal inflammation.
  • To explore the potential therapeutic applications of targeting the endocannabinoid system in inflammatory conditions.

Main Methods:

  • Literature review of existing data on the endocannabinoid system in the gastrointestinal tract.

Related Experiment Videos

  • Analysis of findings from animal models and human studies of inflammatory disorders.
  • Main Results:

    • The endocannabinoid system is identified within the gastrointestinal system, regulating key digestive processes.
    • Evidence suggests overstimulation of the endocannabinoid system during gastrointestinal inflammation in both animal and human studies.

    Conclusions:

    • Gastrointestinal endocannabinoid overactivity during inflammation has pathological significance.
    • This overactivity presents potential therapeutic targets for managing gastrointestinal inflammatory disorders.